Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@argadargada is spot on. People taking profit because they think nanopore IPO is now priced in - it's not! As previously stated likely IPO will likely be in £4-7bn range and nanopore market cap could quickly ramp once listed as retail investors (including me) get in, so we can expect a VERY healthy IP group realisation down the line. Swing traders, do take your marginal profits, but know you'll miss out in the short term (next few weeks)
From today’s Telegraph:
“Analysts reckon the company could be worth up to £17bn’.
No ramping just passing on what is in the Telegraph and curious to know why people are selling when the IPO hasn’t even occurred yet. I’ve held the shares for quite a while through its previous lives as Imperial Innovations and Touchstone. No intention of selling. I’m quite happy to wait for the “special dividend” and any future IPOs.
IP group will do very well, keeping it real it’s 15% of 3 billion, not £17b - Cut the BS and ramping eh.
Just imagine if it IPO’s for £17bn and you’d sold!
Well, estimates of the value of the IPO vary wildly from £2.4bn to £17bn, but a conservative valuation of £4.5bn would mean IP Group’s 15% holding would be worth £600m and the board have stated that any “one off” realisation would be returned to shareholders after retaining some money for future investments. Why anyone would sell now is beyond me. Surely that’s a huge buy signal.
Do these idiots cashing in now not do sums? 15% of £7 Billion (expected Nano opening value) is £1Billion !!! And that is valuing all our other interests at zero. And they are selling!
Global institutions will be competing to participate in nanopore IPO. Including for example Tencent (who already have a small stake in nanopore) and Softbank. It is going to get VERY interesting.....
Everything you need to know here. IPO microsite
https://nanoporetech.com/about-us/investors/documents
This is flying now.......
I genuinely hope many of you loaded up at sub 100pps as I did. More to come here in run up to nanopore IPO and afterwards. Market finally realising we have a global blockbuster tech company entering the FTSE!!
nearly 50% up since July, nice
@mradventurous, not sure if retail investors will be included for nanopore IPO. If so, best chance is probably Freedom24 (freedom finance)
I thought it was 4.8p not 0.48p no?
And no mention of SUPP's holding but I'm sure they'll catch up! Meanwhile, £7bn for Oxford Nanopore is a conservative valuation.
and you don't have to take my word for it re. the valuation - see recent iii article
https://www.ii.co.uk/analysis-commentary/british-biotech-star-nearing-ps39-billion-ipo-ii521274
@moorhey, sorry but your maths is incorrect. If ONT IPOs at £2.5bn, then IP group NAV gain (vs mid-year results) is £3.5m since NAV already values ONT stake at £359m. However, ONT valuation for IPO is highly likely to exceed £2.5bn - note in the Reuters announcement that they will build on the May valuation. I'd be very surprised (as explained in previous posts) if IPO was for less than £3bn and more likely in £4-7bn range, which would translate to hard NAV of £1.66bn-£2bn or £1.5-£2 per share. We may also see ONT shareprice/market cap gain rapidly after listing as retail investors take positions, which would translate to further NAV gain for IP group. We shall see soon enough.......
What a dipstick!
I only put the decimal point in the wrong place, its 0.48p per share not 48p!!!
"There's already a special dividend of 48p being paid on 27th September"
My guess @Millikino is that there will be another special dividend issued.
I'm not sure of my maths - maybe someone else can verify.
If ONT has an IPO of £2.48bn and IPGroup own 15% ; their share is worth £375m and with a billion shares in IPGroup, that's approx 37p per share.
There's already a special dividend of 48p being paid on 27th September, so I'd expect a drop in the SP after that (in normal circumstances) to about 100p; but this news is probably why the SP is holding-up and still going up.
Of course, I could be completely wrong, so DYOR.
...would be daft enough to sell these NOW?!
another very good day here,nice
Whats everyone's best guess for the share price post IPO? Circa £2 in the offer, or perhaps higher?
@moorhey - it's a pleasure. I have researched & invested in genomics and sequencing space for quite some time (since circa 2007) so glad my insight is proving useful to others. And it's nice to call it right every now and then! Back in 2007 I invested in Illumina, I exited way too early. Since, I've better researched the addressable markets for next gen sequencing, long read sequencing, and diagnostic sequencing, and I won't make the same mistake twice with ONT or PACB (which I'm also invested in since 2012)
Prospects for ONT are incredible, their IPO really is just the beginning IMO. I'll be accumulating ONT stock for the next few years, as well as holding onto my core IP group holding as I think a very solid long term investment due to the diversity in their portfolio and strong financials. Good luck to all here over coming weeks
Well done!
I thought the IPO would be much later in the year.
Based on your confidence I doubled my holding on 17th August - I owe you a pint @danrh
(Alliance News) - IP Group PLC investee Oxford Nanopore Technologies Ltd is planning to launch an initial public offering in the coming weeks, Reuters reported on Wednesday.
The life sciences firm, which intellectual property-focused investor IP Group has a roughly 15% stake in, is working with banks for a London Main Market float.
Oxford Nanopore is eyeing to build on its GBP2.48 billion valuation it achieved during a funding round in May, Reuters reported, citing two sources familiar with the matter.
Reuters reported that Bank of America Corp, Citigroup Inc and JPMorgan Chase & Co are global coordinators for the listing.
https://www.reuters.com/article/oxford-nanopore-ipo/oxford-nanopore-to-launch-3-4-billion-london-ipo-in-coming-weeks-sources-idUSKBN2FX3KG?feedType=RSS&feedName=healthNews
The IPO would represent a big win for London's Main Market. Biotechnology firms have previously listed on the junior AIM market or have looked to make a mark on the Nasdaq in the US. Vaccitech PLC, which like Oxford Nanopore is a University of Oxford spin-out, opted to overlook London markets entirely to list on the Nasdaq back in April. AIM-listed life science research tools firm Abcam is also Nasdaq-listed.
IP Group shares surged 9.3% to 138.80 pence each in London on Wednesday afternoon, the best mid-cap performer.
and i bet more to come tomorrow , nice